Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting

Objective: Programmed death-ligand-1 (PDL1) is a molecule involved in immune evasion in various kinds of tumors. Here, we aim to determine whether the expression of PDL1 protein is related to the response of patients to neoadjuvant therapy and survival outcome. Methods: Immunohistochemistry (IHC) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ziping, Zhang, Lei, Peng, Jing, Xu, Shuguang, Zhou, Liheng, Lin, Yanpin, Wang, Yan, Lu, Jinglu, Yin, Wenjin, Lu, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605984/
https://www.ncbi.nlm.nih.gov/pubmed/30866717
http://dx.doi.org/10.1080/15384047.2019.1583533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605984/
https://www.ncbi.nlm.nih.gov/pubmed/30866717
http://dx.doi.org/10.1080/15384047.2019.1583533

Ejemplares similares